[RPRX] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[RPRX] Royalty Pharma plc
Announcement Date
08-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -28.46%
YoY- 113.71%
Quarter Report
RPRX's Result
RPRX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
Revenue 564,690 536,313 573,463 585,773 539,000 464,277 3.98%
PBT 806,358 122,077 220,414 221,796 624,000 440,027 12.86%
Tax 0 49,963 2,582 119,867 333,622 92,031 -
NP 543,987 72,114 217,832 101,929 291,000 408,982 5.86%
Tax Rate 0.00% -40.93% -1.17% -54.04% -53.47% -20.91% -
Total Cost 20,703 464,199 355,631 483,844 248,000 55,295 -17.82%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
NP Margin 96.33 13.45 37.99 17.40 53.99 88.09 1.80%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
EPS 1.61 0.16 0.36 0.24 0.79 1.15 6.95%
EPS Diluted 1.21 0.16 0.36 0.24 0.79 1.15 1.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.